Clinical trials
Completed Heart Failure trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 6 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 5 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 64 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 12 |
| AstraZeneca | 7 |
| I.M. Sechenov First Moscow State Medical University | 5 |
| Cytokinetics | 4 |
| National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | 4 |
| Bristol-Myers Squibb | 2 |
| Janssen Research & Development, LLC | 2 |
| Medtronic Cardiac Rhythm and Heart Failure | 2 |
| Moscow Regional Research and Clinical Institute (MONIKI) | 2 |
| National Research Center for Preventive Medicine | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 64 |
| Cardiovascular Diseases | 6 |
| Atrial Fibrillation | 4 |
| Diabetes Mellitus, Type 2 | 4 |
| Hypertension | 4 |
| Myocardial Infarction | 4 |
| Renal Insufficiency, Chronic | 4 |
| Stroke | 4 |
| Coronary Artery Disease | 3 |
| Dyspnea | 3 |
Trials
Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.